PepGen Inc. Being Investigated on Behalf of PepGen Inc. Investors. Contact Levi & Korsinsky For Details
Portfolio Pulse from
PepGen Inc. is under investigation by Levi & Korsinsky for potential federal securities law violations. The company has voluntarily paused its Phase 2 CONNECT2-EDO51 study for Duchenne muscular dystrophy to review results from another ongoing study.
March 13, 2025 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
PepGen Inc. is being investigated for potential securities law violations and has paused a key clinical trial, which could impact investor confidence and stock price.
The investigation into potential securities law violations and the pause of a clinical trial are significant events that could negatively impact investor confidence and the stock price of PepGen Inc. in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100